Clinical Trials Results - National Cancer Institute

Skip to content

National Cancer Institute
U.S. National Institutes of Health | www.cancer.gov


	Clinical Trials Search Results

	Quick Links


	Director's Corner Dictionary of Cancer Terms NCI Drug Dictionary Funding Opportunities NCI Publications Advisory Boards and Groups Science Serving People Español

Questions about cancer?


	1-800-4-CANCER

	LiveHelp® online chat

	NCI Highlights


	Virtual and Standard Colonoscopy Both Accurate Denosumab May Help Prevent Bone Loss Past Highlights



Results: 1 -5 of 5 Show results per page	View Search Criteria \| Help With Results


Sort By:	Version:	Format:


1.		Safety and Efficacy Study of a New Chemotherapy Agent to Treat Non-Small-Cell Lung Cancer

	Phase				Type				Status				Age				Sponsor				Protocol IDs

	Phase II				Treatment				Closed				18 and over				Pharmaceutical / Industry				91374 EudraCT: 2005-000586-19, 307971, NCT00160069


2.		Efficacy and Safety Study of ZK219477 in Patients With Recurrent Ovarian Cancer

	Phase				Type				Status				Age				Sponsor				Protocol IDs

	Phase II				Treatment				Completed				18 and over				Pharmaceutical / Industry				307970 EudraCT No: 2005-000635-15, NCT00246688


3.		ZK-Epo Given With Carboplatin in Patients With Recurrent Ovarian Cancer

	Phase				Type				Status				Age				Sponsor				Protocol IDs

	Phase II				Treatment				Closed				18 and over				Pharmaceutical / Industry				91476 307979, NCT00325351

Last Modified: 8/14/2008 First Published: 1/5/2007


4.		Phase II Study of Epothilone ZK-219477 in Patients With Recurrent Glioblastoma

	Phase				Type				Status				Age				Sponsor				Protocol IDs

	Phase II				Biomarker/Laboratory analysis, Treatment				Closed				18 and over				Other, Pharmaceutical / Industry				EORTC-26061 EUDRACT-2006-001659-37, NCT00424060, SPRI-EORTC-26061


5.		Investigation Into How the Body Takes up the Test Drug and Distributes it Into Various Body Organs and Tissues, How it Processes the Drug and How it Ultimately Removes it

	Phase				Type				Status				Age				Sponsor				Protocol IDs

	Phase I				Biomarker/Laboratory analysis, Treatment				Completed				18 and over				Pharmaceutical / Industry				91490 EUDRA-CT 2006-000188-26, 310301, NCT00432302

Select All on One Page

| | | | | | | |

A Service of the National Cancer Institute